NASDAQ
COSCIENS Biopharma Inc. (CSCI) has a free cash flow growth of -80.75% as of Friday, May 29, 2026. This represents a 14.99% decrease compared to its 12-month average of -70.22%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.